May 14, 2019 Duesseldorf, May 14, 2019 – Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. “I very much welcome the financial expertise and years of industry experience... Read more
Dr. Bernd Metzner Duesseldorf, November 28, 2018 – Dr. Bernd Metzner (48) is to become Chief Financial Officer of Gerresheimer AG, taking up office at the latest on July 1, 2019. Dr. Bernd Metzner has been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. “In Dr. Bernd Metzner, we have gained... Read more
DÜSSELDORF, Germany, October 11, 2018 /PRNewswire/ — Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m Adjusted EBITDA at constant exchange rates–excluding Sensile Medical and negative effects relating to the exemption from electricity network charges–increased by EUR 1.3m in third quarter to EUR 79.5m Integration of Sensile Medical proceeding to plan; first product gains CE declaration of... Read more
DÜSSELDORF, Germany, October 11, 2018 /PRNewswire/ — Andreas Schütte (56) will step down from the Management Board of Gerresheimer AG at his own request as of February 28, 2019 in order to pursue new career challenges. The Supervisory Board of Gerresheimer AG approved this wish at its meeting yesterday. Andreas Schütte has served on the Management Board of Gerresheimer AG since 2009 with responsibility for the Plastics & Devices and Advanced... Read more